JPWO2020065023A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020065023A5 JPWO2020065023A5 JP2021517009A JP2021517009A JPWO2020065023A5 JP WO2020065023 A5 JPWO2020065023 A5 JP WO2020065023A5 JP 2021517009 A JP2021517009 A JP 2021517009A JP 2021517009 A JP2021517009 A JP 2021517009A JP WO2020065023 A5 JPWO2020065023 A5 JP WO2020065023A5
- Authority
- JP
- Japan
- Prior art keywords
- mhc
- minimal
- epitope
- score
- epitopes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18197172.2 | 2018-09-27 | ||
| EP18197172 | 2018-09-27 | ||
| PCT/EP2019/076210 WO2020065023A1 (en) | 2018-09-27 | 2019-09-27 | Method for selecting neoepitopes |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022502416A JP2022502416A (ja) | 2022-01-11 |
| JP2022502416A5 JP2022502416A5 (https=) | 2022-09-27 |
| JPWO2020065023A5 true JPWO2020065023A5 (https=) | 2022-09-27 |
| JP7585195B2 JP7585195B2 (ja) | 2024-11-18 |
Family
ID=63794302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517009A Active JP7585195B2 (ja) | 2018-09-27 | 2019-09-27 | ネオエピトープを選択する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12462898B2 (https=) |
| EP (1) | EP3856957A1 (https=) |
| JP (1) | JP7585195B2 (https=) |
| KR (1) | KR102902460B1 (https=) |
| CN (1) | CN112771214B (https=) |
| AU (1) | AU2019346023B2 (https=) |
| BR (1) | BR112021005702A8 (https=) |
| CA (1) | CA3111903A1 (https=) |
| IL (1) | IL281771B2 (https=) |
| MX (1) | MX2021003654A (https=) |
| SG (1) | SG11202101965QA (https=) |
| WO (1) | WO2020065023A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020221783A1 (en) * | 2019-04-29 | 2020-11-05 | Vaccibody As | Methods for pre-selection of neoepitopes |
| US20230197192A1 (en) * | 2020-11-06 | 2023-06-22 | Amazon Technologies, Inc. | Selecting neoantigens for personalized cancer vaccine |
| GB202102606D0 (en) * | 2021-02-24 | 2021-04-07 | Univ Oxford Innovation Ltd | Treatment of ovarian cancer minimal residual disease |
| IL305777A (en) | 2021-03-26 | 2023-11-01 | Nykode Therapeutics ASA | Medical combination for cancer treatment |
| WO2022238420A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Co-expression of constructs and immunostimulatory compounds |
| WO2022238381A2 (en) | 2021-05-10 | 2022-11-17 | Nykode Therapeutics ASA | Immunotherapy constructs for treatment of disease |
| WO2023244997A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of North Carolina At Chapel Hill | Compositions and methods for inducing anticancer immunity |
| EP4608436A1 (en) | 2022-10-25 | 2025-09-03 | Nykode Therapeutics ASA | Constructs and their use |
| KR102857635B1 (ko) * | 2022-11-08 | 2025-09-10 | 인바이츠지노믹스 주식회사 | 면역원성이 높은 유사체를 디자인하는 방법 및 이를 이용한 장치 |
| WO2024100196A1 (en) | 2022-11-09 | 2024-05-16 | Nykode Therapeutics ASA | Co-expression of constructs and polypeptides |
| WO2024216073A1 (en) * | 2023-04-14 | 2024-10-17 | The Trustees Of Columbia University In The City Of New York | Engineered microbes comprising tumor neoantigen vectors for cancer immunotherapy |
| US20250232833A1 (en) * | 2024-01-13 | 2025-07-17 | Noergaard Anders Kaare | Cyclin D1 Based Cancer Vaccine |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012029066A2 (pt) | 2010-05-14 | 2020-09-01 | The General Hospital Corporation | composições e processos de identificação de neoantígenos específicos de tumor. |
| HRP20211595T1 (hr) | 2011-05-24 | 2022-01-21 | BioNTech SE | Individualizirana cjepiva protiv raka |
| WO2014082729A1 (en) | 2012-11-28 | 2014-06-05 | Biontech Ag | Individualized vaccines for cancer |
| CN118750591A (zh) | 2013-04-07 | 2024-10-11 | 博德研究所 | 用于个性化瘤形成疫苗的组合物和方法 |
| WO2014180490A1 (en) | 2013-05-10 | 2014-11-13 | Biontech Ag | Predicting immunogenicity of t cell epitopes |
| JP6558699B2 (ja) | 2013-10-01 | 2019-08-14 | 国立大学法人三重大学 | 抗原提示を促進するエピトープ間配列を含むｔ細胞誘導ワクチン |
| US11186640B2 (en) | 2014-07-31 | 2021-11-30 | The University Of Western Australia | Method for the identification of immunotherapy-drug combinations using a network approach |
| EP3193892A4 (en) | 2014-09-14 | 2018-09-12 | Washington University | Personalized cancer vaccines and methods therefor |
| US10317402B2 (en) | 2014-12-03 | 2019-06-11 | Verik Bio, Inc. | Identification, selection and use of high curative potential T cell epitopes |
| WO2016128060A1 (en) * | 2015-02-12 | 2016-08-18 | Biontech Ag | Predicting t cell epitopes useful for vaccination |
| CA2988388C (en) * | 2015-04-23 | 2022-11-22 | Nantomics, Llc | Cancer neoepitopes |
| SG10201912485PA (en) * | 2015-05-13 | 2020-02-27 | Agenus Inc | Vaccines for treatment and prevention of cancer |
| EP3323070B1 (en) * | 2015-07-14 | 2024-05-08 | Personal Genome Diagnostics Inc. | Neoantigen analysis |
| RU2729116C2 (ru) | 2015-12-16 | 2020-08-04 | Гритстоун Онколоджи, Инк. | Идентификация, производство и применение неоантигенов |
| WO2018136664A1 (en) * | 2017-01-18 | 2018-07-26 | Ichan School Of Medicine At Mount Sinai | Neoantigens and uses thereof for treating cancer |
| EP3678699A1 (en) | 2017-09-07 | 2020-07-15 | University Of Oslo | Vaccine molecules |
-
2019
- 2019-09-27 CN CN201980063254.9A patent/CN112771214B/zh active Active
- 2019-09-27 JP JP2021517009A patent/JP7585195B2/ja active Active
- 2019-09-27 BR BR112021005702A patent/BR112021005702A8/pt unknown
- 2019-09-27 WO PCT/EP2019/076210 patent/WO2020065023A1/en not_active Ceased
- 2019-09-27 EP EP19773458.5A patent/EP3856957A1/en active Pending
- 2019-09-27 AU AU2019346023A patent/AU2019346023B2/en active Active
- 2019-09-27 KR KR1020217012734A patent/KR102902460B1/ko active Active
- 2019-09-27 CA CA3111903A patent/CA3111903A1/en active Pending
- 2019-09-27 US US17/279,946 patent/US12462898B2/en active Active
- 2019-09-27 MX MX2021003654A patent/MX2021003654A/es unknown
- 2019-09-27 SG SG11202101965QA patent/SG11202101965QA/en unknown
- 2019-09-27 IL IL281771A patent/IL281771B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502416A5 (https=) | ||
| Clark et al. | Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data | |
| Blöcker et al. | Epitope mapping of BP230 leading to a novel enzyme‐linked immunosorbent assay for autoantibodies in bullous pemphigoid | |
| Dick et al. | Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis | |
| Ota et al. | Multi-omics approach to precision medicine for immune-mediated diseases | |
| JP7585195B2 (ja) | ネオエピトープを選択する方法 | |
| JPWO2020065023A5 (https=) | ||
| BR112020023587A2 (pt) | método para determinar um perfil de fragmentação de dna livre de células (cfdna), método para identificar um mamífero como tendo câncer, método de identificação do tecido de origem de um câncer e método para tratar um mamífero com câncer | |
| JP7066139B2 (ja) | ワンステップ逆転写テンプレートスイッチｐｃｒを利用したｔ細胞受容体およびｂ細胞受容体レパトア解析システム | |
| WO2018183980A2 (en) | Ranking system for immunogenic cancer-specific epitopes | |
| CN105524984A (zh) | 预测新抗原表位的方法及设备 | |
| WO2009040782A2 (en) | A method of assessing colorectal cancer status in an individual | |
| JP4201057B2 (ja) | ヒト転移サプレッサー遺伝子ｋａｉｉに由来する試薬を使用する診断方法及び遺伝子療法 | |
| JP2011524977A (ja) | ループスのためのバイオマーカー | |
| EP1384079A2 (en) | Proteins, genes and their use for diagnosis and treatment of breast cancer | |
| Quintana-Duque et al. | Predictors of remission, erosive disease and radiographic progression in a Colombian cohort of early onset rheumatoid arthritis: a 3-year follow-up study | |
| Yu et al. | Current HLA testing recommendations to support HCT | |
| Xu et al. | Learning the drug target‐likeness of a protein | |
| Cheng et al. | Clinical expression and antigenic profiles of a Plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7) | |
| CN114530202A (zh) | 鉴定抗原特异性tcr或bcr的方法及应用 | |
| Dopico et al. | Untangling associations between immunoglobulin genotypes, repertoires and function | |
| JPH0231958B2 (https=) | ||
| Zhou et al. | Single nucleotide polymorphisms in PDCD6 gene are associated with the development of cervical squamous cell carcinoma | |
| CN113718027B (zh) | 新型fbn2基因突变标志物及其在cca辅助诊断中的应用 | |
| AU2534999A (en) | Methods and compositions for diagnosis of hepatoma |